- $1.47bn
- $1.58bn
- $418.84m
U.S. RESEARCH ROUNDUP- Celsius Holdings, RPT Realty, Thorne Healthtech
U.S. RESEARCH ROUNDUP-Appfolio, Iron Mountain, Neogenomics
U.S. RESEARCH ROUNDUP-Caci International, Cyberark Software, Ralph Lauren
U.S. STOCKS ON THE MOVE-Air Transport Services Group, Dillard's, Precigen
U.S. STOCKS ON THE MOVE-Capri Holdings, Amyris, gold miners
Certara down on weak full-year outlook
U.S. STOCKS ON THE MOVE-YETI Holdings, Catalyst Pharma, ZimVie
Certara down on weak full-year outlook
U.S. RESEARCH ROUNDUP-Penn Entertainment, Roblox, Sonendo
Certara Inc reports results for the quarter ended in June - Earnings Summary
Brief: Certara Q2 Adjusted EPS USD 0.12 Vs. IBES Estimate USD 0.13
Certara Inc expected to post earnings of 13 cents a share - Earnings Preview
U.S. RESEARCH ROUNDUP-Booking Holdings, Qualys, ServiceNow
Certara Inc reports results for the quarter ended in March - Earnings Summary
Brief: Certara Inc Reiterating 2023 Financial Outlook
Brief: Certara Reiterating 2023 Financial Outlook
Certara Inc expected to post earnings of 12 cents a share - Earnings Preview
U.S. RESEARCH ROUNDUP- Ameresco, Bioxcel Therapeutics, Roblox
Brief: Certara Announces Release Of Simcyp™ PBPK Simulator Version 22, Expanding Ability To Simulate Untested Scenarios For New Patient And Therapeutic Types